Skip to main content
See every side of every news story
Published loading...Updated

Reasons for Maintaining the Classification of Esmethadone as an Investigational Uncompetitive NMDAR Antagonist Rapid Antidepressant: Reply to Ferré and Michaelides

Summary by psychiatrist.com
Reasons for Maintaining the Classification of Esmethadone as an Investigational Uncompetitive NMDAR Antagonist Rapid Antidepressant: Reply to Ferré and Michaelides See letter by Ferré and Michaelides and article by Fava et al To the Editor: We appreciate the opportunity to respond to the letter by Drs Ferré and Michaelides1 regarding the mechanistic characterization of esmethadone (S-methadone). In their letter, Ferré and Michaelides raise two m…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

psychiatrist.com broke the news in on Monday, September 8, 2025.
Sources are mostly out of (0)
News
For You
Search
BlindspotLocal